Westend Capital Management’s Idexx Laboratories IDXX Stock Holding History

Westend Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.3K	Hold	13	–	–	﹤0.01%	176
2025 Q4	$8.79K	Hold	13	–	–	﹤0.01%	161
2025 Q3	$8.31K	Hold	13	–	–	﹤0.01%	151
2025 Q2	$6.97K	Hold	13	–	–	﹤0.01%	145
2025 Q1	$5.46K	Hold	13	–	–	﹤0.01%	149
2024 Q4	$5.38K	Hold	13	–	–	﹤0.01%	157
2024 Q3	$6.57K	Hold	13	–	–	﹤0.01%	149
2024 Q2	$6.19K	Hold	13	–	–	﹤0.01%	128
2024 Q1	$7.02K	Buy	+13	New	+$7.1K	﹤0.01%	140

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Westend Capital Management's IDXX Position: Q1 2026 in Review

Westend Capital Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 13 shares worth $7.3K. The position accounts for ﹤0.01% of the portfolio, ranked #176.

Westend Capital Management first reported a position in IDXX in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.79K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Westend Capital Management held 13 shares of Idexx Laboratories worth $7.3K as of Q1 2026.
Westend Capital Management left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up ﹤0.01% of Westend Capital Management's portfolio in Q1 2026, its #176 holding.
Westend Capital Management first reported a position in Idexx Laboratories in Q1 2024 and has held it in 9 quarters since.
Westend Capital Management's Idexx Laboratories position peaked at $8.79K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Westend Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.